By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
May 23, 2017/Test & Measure
Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.
Jun 28, 2017/Test & Measure
Used during systems review to identify cognitive impairment in various patient populations.
Aug 23, 2017/Test & Measure
A 6 point Oxford scale (0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong) used during internal examination to measure pelvic floor muscle strength in women. (4)
Apr 1, 2024/CPG
Best practice statements provide guidance for clinicians about the preferred characteristics of 3-dimensional instrumented gait analysis laboratories, including instrumentation, staffing, and reporting practices.
Jan 10, 2013/Test & Measure
For patients with foot and ankle disorders
Used to evaluate symptoms of Achilles tendinopathy and their effect on physical activity; can be used to determine clinical severity and provide a guideline for treatment and for monitoring the effect of treatment.
Sep 11, 2023/Test & Measure
Used to stage Parkinson disease by level of severity related to impairments, especially postural instability, and activity limitations.
May 21, 2013/Test & Measure
Berg Balance Scale for Multiple Sclerosis
Jun 15, 2013/Test & Measure
Measures disorders of the upper limbs; change or function over time.
Jun 16, 2013/Test & Measure
Measures static and dynamic balance under varying sensory conditions; designed to measure balance in higher-functioning active older adults.